Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Instead of several months, treatment may extend to a year or more
Over the past decade, four landmark cardiovascular outcome trials have quietly rewritten how we think about cardiometabolic risk: LEADER (2016) Liraglutide cut MACE by 13%, CV death by 22%, and all-cause mortality by 15% in high-risk T2DM patients
This work was supported by the Cangzhou Science and Technology Plan Self-financed Project (2023-202423244102075), the Military Key Discipline Construction Projects of China (HL21JD1206), and the National Natural Science Foundation of China (82401967)
Salerno offers personalized treatment plans based on the latest advancements in diabetes care and weight loss strategies
US$ 22.10
US$ 29.21
US$ 22.76
US$ 20.91
US$ 27.65
US$ 27.57
